Bayer and Kumquat launch a phase I study of KQB548, aiming to target various KRAS G12D-mutated tumors like pancreatic, ...

There is no cost to meet MI Options counselors, who are not affiliated with health insurance companies so they don’t have an incentive to point you to a particular plan or company.

New doctor directories, updated drug costs, and a pilot run in New Jersey of using artificial intelligence to approve certain procedures are among the changes coming to Medicare in 2026. Medicare’s ...